Seres Therapeutics, Inc. Property, Plant and Equipment
Seres Therapeutics, Inc. (MCRB) had Property, Plant and Equipment of $5.80 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentNet · last filed 2026-08-05
- 2026-06-30: Property, Plant and Equipment, Net $5.80M.
- 2026-03-31: Property, Plant and Equipment, Net $6.85M.
- 2025-12-31: Property, Plant and Equipment, Net $7.63M.
- 2025-09-30: Property, Plant and Equipment, Net $8.58M.
| Period end | Property, Plant and Equipment, Net | Property, Plant and Equipment, Net as first filed |
|---|---|---|
| 2026-06-30 | $5.80M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $6.85M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $7.63M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $8.58M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $9.62M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $10.55M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $11.53M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $12.57M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $17.79M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $19.11M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $17.61M 10-K · filed 2025-03-13 | $22.46M 10-K · filed 2024-03-05 |
| 2023-09-30 | $23.57M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $24.03M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $24.31M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $22.98M 8-K · filed 2024-08-15 | |
| 2022-09-30 | $19.48M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $19.52M 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $19.07M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $17.94M 10-K · filed 2023-03-07 | |
| 2021-09-30 | $17.36M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $15.05M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $13.58M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $13.90M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $14.73M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $16.30M 10-Q · filed 2020-07-28 | |
| 2020-03-31 | $17.84M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $19.50M 10-K · filed 2021-03-02 | |
| 2019-09-30 | $21.16M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $22.95M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $24.57M 10-Q · filed 2019-05-02 | |
| 2018-12-31 | $26.29M 10-K · filed 2020-03-02 | |
| 2018-09-30 | $28.08M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $29.90M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $31.47M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $32.93M 10-K · filed 2019-03-06 | |
| 2017-09-30 | $33.72M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $34.81M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $36.09M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $36.13M 10-K · filed 2018-03-08 | |
| 2016-09-30 | $34.56M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $26.98M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $16.08M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $7.75M 10-K · filed 2017-03-16 | |
| 2015-09-30 | $4.54M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $3.32M 10-Q · filed 2015-08-10 | |
| 2014-12-31 | $1.26M 10-K · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |